Shield Therapeutics (STX) News Today

→ 2024's Must-Have Guide: Master Crypto Investment Today (From Darwin) (Ad)

GBX 1.48

0.00 (0.00%)

(As of 04/18/2024 ET)

Stock Analysis Chart Competitors Headlines

Source

Source	Headline
	Neutral Switzerland joins European Sky Shield defence project msn.com - April 10 at 7:15 AM
	American Home Shield Offering 40% Off ShieldGold™ For Limited Time tmcnet.com - April 1 at 3:14 PM
	A Real Life Invisibility Shield for Privacy in Public Places msn.com - March 29 at 4:58 PM
	Seal Shield to Showcase Shyld AI, the World's First Intelligent, Autonomous, UV-C Disinfection System at HIMSS 2024 tmcnet.com - March 11 at 10:35 AM
	LONDON MARKET CLOSE: FTSE 100 takes hit ahead of FOMC minutes lse.co.uk - February 23 at 4:14 PM
	Shield Therapeutics PLC STX morningstar.com - February 22 at 2:15 PM
	Shield Therapeutics plc (STX.L) uk.finance.yahoo.com - February 13 at 7:26 PM
	Shield Therapeutics (LON:STX) shareholders have endured a 89% loss from investing in the stock three years ago finance.yahoo.com - January 24 at 4:20 AM
	Shield Therapeutics plc (LON:STX) Is Expected To Breakeven In The Near Future finance.yahoo.com - December 28 at 9:53 AM
	Shield Therapeutics to present at NPWH conference this month proactiveinvestors.com - October 20 at 9:58 AM
	Shield Therapeutics CFO Hans-Peter Rudolf to Step Down marketwatch.com - October 12 at 9:11 AM
	Shield Therapeutics launches executive search process as CFO steps down proactiveinvestors.com - October 12 at 9:11 AM
	Shield Therapeutics "couldn't be more pleased" with Viatris collaboration finance.yahoo.com - October 5 at 7:44 AM
	Shield Therapeutics' pricing will be "key metric" - Proactive Research Analyst finance.yahoo.com - October 5 at 7:44 AM
	Shield Therapeutics secures debt facility, retail share offer closes soon proactiveinvestors.com - October 3 at 5:49 AM
	Shield Therapeutics First Half 2023 Earnings: US$0.025 loss per share (vs US$0.069 loss in 1H 2022) finance.yahoo.com - September 30 at 7:42 AM
	Shield Therapeutics hails progress in Stateside venture as losses narrow msn.com - September 29 at 10:05 AM
	Shield Therapeutics Shares Fall After Discounted Equity Raise marketwatch.com - September 28 at 8:20 AM
	Private companies who hold 41% of Shield Therapeutics plc (LON:STX) gained 17%, institutions profited as well finance.yahoo.com - September 5 at 6:53 AM
	Shield Therapeutics : First signs of hoped-for Accrufer Rx inflection proactiveinvestors.com - July 29 at 6:37 AM
	Hardman & Co Research on Shield Therapeutics (STX): Accrufer Rx momentum gathering finanznachrichten.de - July 25 at 10:39 AM
	Shield Therapeutics "really starting to fire on all cylinders" finance.yahoo.com - July 25 at 10:39 AM
	Shield Therapeutics Shares Rise as US Prescriptions for Accrufer Soar marketwatch.com - July 20 at 2:17 PM
	Shield Therapeutics makes waves in US as iron deficiency prescriptions ramp up msn.com - July 20 at 9:17 AM
	Shield Therapeutics reports 173% Accrufer prescription growth proactiveinvestors.com - July 20 at 9:17 AM
	Save $30 on the Nvidia Shield Android TV for Amazon Prime Day msn.com - July 11 at 10:14 PM
	Neutral Swiss join Europe's Sky Shield defence msn.com - July 7 at 11:24 AM
	Swiss Want In On Germany's Sky Shield Plan barrons.com - July 4 at 4:01 PM
	Hardman & Co Research on Shield Therapeutics (STX): Reassuring 1Q’23 Accrufer prescriptions uk.movies.yahoo.com - May 17 at 8:54 AM
	Shield Therapeutics directors urge rejection of mandatory offer proactiveinvestors.com - May 4 at 4:28 PM
	Shield Therapeutics well positioned with "great partnership" - Proactive Research Analyst proactiveinvestors.com - May 2 at 3:17 PM
	Shield Therapeutics ready to go full throttle in the US proactiveinvestors.com - April 27 at 7:59 AM
	Shield Therapeutics appoints chief commercial officer as group readies for US sales offensive proactiveinvestors.com - April 5 at 8:50 AM
	Loss-Making Shield Therapeutics plc (LON:STX) Expected To Breakeven In The Medium-Term finance.yahoo.com - March 27 at 8:33 AM
	Shield Therapeutics "ended 2022 in a very very productive state" finance.yahoo.com - February 13 at 11:02 AM
	Proactive research analyst says Shield Therapeutics "in fast growth mode" finance.yahoo.com - February 13 at 11:02 AM
	Privacy Shield: The Six Things You Need to Know That Might Affect Your Company benzinga.com - February 9 at 2:39 PM
	Shield Therapeutics primed for a strong year as it confirms plans to become self-sufficient proactiveinvestors.com - February 9 at 8:51 AM
	Shield Therapeutics shares jump 13%; broker sets punchy price target proactiveinvestors.com - February 9 at 8:51 AM
	Hardman & Co Q&A on Shield Therapeutics (STX): Positioned for profitability with Viatris deal and its additional capital markets.businessinsider.com - January 23 at 8:06 AM
	Hardman & Co Research: Shield Therapeutics (STX) - Positioned for growth and profitability uk.finance.yahoo.com - January 13 at 9:36 AM
	Proactive research analyst on Shield Therapeutics proactiveinvestors.com - December 14 at 8:28 AM
	Shield Therapeutics completes fundraise proactiveinvestors.com - December 14 at 8:28 AM
	Shield Therapeutics secures £15.1m in raise and seals deal with healthcare company msn.com - December 13 at 5:26 PM
	Shield Therapeutics agrees US partnership to promote Accrufer, launches equity funding proactiveinvestors.com - December 13 at 6:36 AM
	Shield Therapeutics’ lead product Accrufer expected to gain Korean regulatory approval in 2023 proactiveinvestors.com - October 31 at 7:24 AM
	Shield Therapeutics says lead product expected to gain Korean regulatory approval in 2023 proactiveinvestors.com - October 31 at 7:24 AM
	Shield Therapeutics’ lead product Accrufer® has shelf-life extended to 48 months proactiveinvestors.com - October 27 at 6:22 AM
	Shield Therapeutics plc's (LON:STX) Profit Outlook finance.yahoo.com - October 17 at 6:33 PM
	Hardman & Co Research on Shield Therapeutics (STX): Accrufer momentum building uk.finance.yahoo.com - September 15 at 2:04 PM

Get Shield Therapeutics News Delivered to You Automatically

Don’t expose yourself to stocks during the week (Ad)

The S&P 500 just crossed below the 200 day moving average… The Nasdaq is bleeding out… Are we headed for a recession?! If you’ve been in the stock market the last few months, it hasn’t been fun… But what if I told you there was a way to target “BONUS” income just by doing a unique type of trade over the weekend? When the markets are closed. And volatility is minimal.

Click here and I’ll give you all the details.

STX Media Mentions By Week

STX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

STX
News Sentiment
▼
0.34

0.49
▲
Average
Medical
News Sentiment

STX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

STX Articles
This Week
▼
0

0
▲
STX Articles
Average Week

Get Shield Therapeutics News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (LON:STX) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Shield Therapeutics (STX) News Today

STX Media Mentions By Week

STX Media Sentiment

STX News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info